These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38057353)

  • 1. Vesical imaging reporting and data system (VI-RADS) could predict the survival of bladder-cancer patients who received radical cystectomy.
    Zhuang J; Cai L; Sun H; Wu Q; Li K; Yu R; Cao Q; Li P; Yang X; Lu Q
    Sci Rep; 2023 Dec; 13(1):21502. PubMed ID: 38057353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
    BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study.
    Kazan O; Gunduz N; Bakir B; Iplikci A; Culpan M; Ersoy B; Yildirim A
    Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):638-644. PubMed ID: 37209783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer.
    Necchi A; Basile G; Gibb EA; Raggi D; Calareso G; de Padua TC; Patanè D; Crupi E; Mercinelli C; Cigliola A; Tateo V; Giannatempo P; Moschini M; Briganti A; Montorsi F; Messina A; Ross JS; Pavlick D; De Cobelli F; Brembilla G
    BJU Int; 2024 Feb; 133(2):214-222. PubMed ID: 37803523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of VI-RADS scoring criteria for predicting oncological outcomes in bladder cancer.
    Kozikowski M; Zagrodzka M; Zawadzki M; Zugaj P; Osiecki R; Rzymkowski F; Śledź M; Sosnowski R; Dobruch J; Giudice FD; Krajewski W
    World J Urol; 2024 Jul; 42(1):438. PubMed ID: 39046595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Additional MRI-Based Morphologic Measurements on the Performance of VI-RADS for Muscle-Invasive Bladder Cancer.
    Gong Y; Cheng Y; Zhang J; Bao ML; Zhu FP; Sun XY; Zhang YD
    J Magn Reson Imaging; 2024 Sep; 60(3):1113-1123. PubMed ID: 38258496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
    Chai JL; Roller LA; Liu X; Lan Z; Mossanen M; Silverman SG; Shinagare AB
    Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer.
    Kimura K; Yoshida S; Tsuchiya J; Kitazume Y; Waseda Y; Tanaka H; Yokoyama M; Toda K; Yoshimura R; Masaya I; Koga F; Tateishi U; Fujii Y
    Eur Radiol; 2023 Sep; 33(9):6245-6255. PubMed ID: 37045982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
    Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
    Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
    AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
    [No Abstract]   [Full Text] [Related]  

  • 12. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
    Arita Y; Kwee TC; Woo S; Shigeta K; Ishii R; Okawara N; Edo H; Waseda Y; Vargas HA
    Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a New Vesical Imaging-Reporting and Data System (VI-RADS)-Based Algorithm for the Management of Bladder Cancer: A Paradigm Shift From the Current Transurethral Resection of Bladder Tumor (TURBT)-Dependent Practice.
    Taguchi S; Watanabe M; Tambo M; Machida H; Yokoyama K; Fukuhara H
    Clin Genitourin Cancer; 2022 Aug; 20(4):e291-e295. PubMed ID: 35346591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report.
    Pecoraro M; Del Giudice F; Magliocca F; Simone G; Flammia S; Leonardo C; Messina E; De Berardinis E; Cortesi E; Panebianco V
    Abdom Radiol (NY); 2022 Feb; 47(2):763-770. PubMed ID: 34919160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.
    Bicchetti M; Simone G; Giannarini G; Girometti R; Briganti A; Brunocilla E; Cardone G; De Cobelli F; Gaudiano C; Del Giudice F; Flammia S; Leonardo C; Pecoraro M; Schiavina R; Catalano C; Panebianco V
    Radiol Med; 2022 Aug; 127(8):881-890. PubMed ID: 35763251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting Muscle Invasion of Bladder Cancer: An Application of Diffusion Kurtosis Imaging Ratio and Vesical Imaging-Reporting and Data System.
    Qin C; Tian Q; Zhou H; Qin Y; Zhou S; Wu Y; Tianjiao E ; Duan S; Li Y; Wang X; Chen Z; Zheng G; Feng F
    J Magn Reson Imaging; 2024 Jul; 60(1):54-64. PubMed ID: 37916908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is high accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) sufficient for its implementation in the urological practice?
    Rysankova K; Hanzlikova P; Zidlik V; Vrtkova A; Slisarenko M; Skarda J; Grepl M; Krhut J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Mar; 167(1):85-90. PubMed ID: 36628563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Makboul M; Farghaly S; Abdelkawi IF
    Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of actual stage prediction using Vesical Imaging Reporting and Data System (VI-RADS) before radical cystectomy for urothelial carcinoma in SUPER-UC-Cx.
    Kim SH; Han JH; Jeong SH; Yuk HD; Jeong CW; Kwak C; Kim HH; Kim SY; Kim TM; Cho JY; Ku JH
    Transl Androl Urol; 2023 Feb; 12(2):168-175. PubMed ID: 36915877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
    Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.